APA

Gridelli C., de Castro Carpeno J., Dingemans A. C., Griesinger F., Grossi F., Langer C., Ohe Y., Syrigos K., Thatcher N., Das-Gupta A., Truman M., Donica M., Smoljanovic V. & Bennouna J. (20191022). Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical Trial. : JAMA oncology.

Chicago

Gridelli Cesare, de Castro Carpeno Javier, Dingemans Anne-Marie C, Griesinger Frank, Grossi Francesco, Langer Corey, Ohe Yuichiro, Syrigos Konstantinos, Thatcher Nick, Das-Gupta Ashis, Truman Matt, Donica Margarita, Smoljanovic Vlatka and Bennouna Jaafar. 20191022. Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical Trial. : JAMA oncology.

Harvard

Gridelli C., de Castro Carpeno J., Dingemans A. C., Griesinger F., Grossi F., Langer C., Ohe Y., Syrigos K., Thatcher N., Das-Gupta A., Truman M., Donica M., Smoljanovic V. and Bennouna J. (20191022). Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical Trial. : JAMA oncology.

MLA

Gridelli Cesare, de Castro Carpeno Javier, Dingemans Anne-Marie C, Griesinger Frank, Grossi Francesco, Langer Corey, Ohe Yuichiro, Syrigos Konstantinos, Thatcher Nick, Das-Gupta Ashis, Truman Matt, Donica Margarita, Smoljanovic Vlatka and Bennouna Jaafar. Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical Trial. : JAMA oncology. 20191022.